In 1986, Loop et al. first illustrated the long-term prognostic benefits of left internal mammary artery (LIMA) to left anterior descending graft. 1 Surgical myocardial revascularisation with coronary artery bypass graft (CABG) surgery is the most commonly performed and preferred strategy for multivessel coronary artery disease. 1,2 In the absence of large enough powered randomized controlled trials (RCTs), recent studies observed that total arterial revascularisation (TAR) utilizing bilateral internal mammary artery (IMA) and radial conduits carry better longevity and reduces postoperative morbidity, particularly in early graft failure, recurrent angina, and redo-CABG surgery. 3,4 However, the potential challenge of TAR-CABG surgery, especially among left main coronary artery disease, depends on the premise that TAR will have a better graft patency rate and postoperative health-related quality of life. [4][5][6] Here, we describe the long-term (≥6 months) survival benefits of myocardial revascularisation with multiple arterial CABG surgery over 20 years in the United Kingdom.
| METHODSA total of 2979 consecutive isolated elective CABG patients at St Georges University Hospital NHS Foundation Trust from April 1999 to March 2020 were studied, and the last day of the census was May 5, 2021. The study population was distributed in four groupsbilateral internal mammary artery + radial (BIMA+R; n = 431), single internal mammary artery + radial ± vein (SIMA+R±V; n = 823), single internal mammary artery − radial ± vein (SIMA−R±V; n = 823), and radial ± vein (R±V; n = 160) groups. The institutional review board clearance was waived as this retrospective analysis of prospectively collected data under the adult National Institute for Cardiovascular Outcomes Research UK database. Study inclusion criteria were isolated CABG with or without prior history of heart surgery, and patients with concomitant valvular, congenital heart diseases were excluded from the study. Multiple arterial graft CABG populations (BIMA+R and SIMA+R±V) have ≥3 arterial grafts, including sequential arterial grafts with the LIMA, right internal mammary artery (RIMA),